Full Text
EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling

Abstract

Authors

Kehinde A. Adedayo

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×